CT scan to measure liver fat in hepatitis B
Part of Digestive system, Infections clinical trials.
This study uses a special CT scan to measure fat in the liver of people with chronic hepatitis B. It aims to see if imaging can help detect fatty liver changes, which is important for managing your liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic hepatitis B (long-term hepatitis B infection).
- You do not have any other chronic liver disease besides hepatitis B.
- Your body mass index (BMI) is 23 or higher.
- You are not pregnant, and you can safely have an MRI (no severe claustrophobia or metal in your body).
- You have not had any suspicious liver lesions, local liver treatments, or surgery/catheters in your liver or spleen.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what factors predict liver inflammation, scarring (fibrosis), and health outcomes in people with long-term hepatitis B or fatty liver disease. The goal is to better understand who is more likely to worsen over time.
This study tests whether a new type of MRI scan can better detect and measure liver disease, including fatty liver and scarring, compared to standard CT scans. If you have chronic liver disease, this study may help improve how we diagnose and track it.
This study tests a noninvasive FibroScan machine to help measure liver fat and possible liver scarring using information collected in a database. It may help researchers improve how liver problems like fat buildup and scarring are identified and tracked.
This trial compares a new ultrasound technique to a standard MRI scan for measuring liver fat. It may help improve how we diagnose and monitor fatty liver disease.
This study looks at how CT scans (detailed X-ray pictures) help diagnose pancreatic cancer or hepatobiliary (liver/bile duct) cancers. It may help your care team better decide what’s going on and plan next treatments.
This study looks at how liver cirrhosis shows up on non-invasive imaging like CT scans, and how those findings relate to outcomes. It may help researchers better understand what scan patterns could signal disease severity.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.